Clinical Trial Results: GT-032 Belapectin Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial results for GT-032 Belapectin in hepatic impairment were completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• GT-032 Belapectin (Belapectin)

Snippet

Sponsor: Galectin Therapeutics Inc. | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2026-07-14